Márta Péntek

Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries

Valentin Brodszky, Petra Baji, Orsolya Balogh et al. · The European Journal of Health Economics · 2014 · 129 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary

Fanni Rencz, Valentin Brodszky, László Gulàcsi et al. · Value in Health · 2020 · 119 citations · Full text

Pharmacy, Economics, Econometrics +16

Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary

Emese Herédi, Fanni Rencz, Orsolya Balogh et al. · The European Journal of Health Economics · 2014 · 98 citations · Full text

Medicine, Dermatology, Clinical Epidemiology +8

Psychometric properties of the Hungarian version of the eHealth Literacy Scale

Zsombor Zrubka, Ottó Hajdú, Fanni Rencz et al. · The European Journal of Health Economics · 2019 · 93 citations · Full text

Social Sciences, Educational Assessment, Educational Measurement +17

Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe

Marianna Cavazza, Yllka Kodra, Patrizio Armeni et al. · The European Journal of Health Economics · 2016 · 87 citations

Pharmacy, Health Sciences, Pharmacoeconomics +15